Please wait while we open this resource.
K
Guidelines & protocols
2026 WHO Malaria Guideline
World Health Organization
PDF2026494 pages3.4 MB
The guideline synthesises systematic review data on seasonal malaria chemoprevention (SMC), transmission‑directed antimalarial (TDA) interventions, and radical cure of Plasmodium vivax. It evaluates outcomes such as clinical malaria incidence, anaemia, severe disease, and safety considerations including G6PD testing. Recommendations are tailored to transmission settings, advising TDA primarily for very low‑to‑low transmission or post‑elimination contexts. The document also addresses implementation issues like feasibility, equity, and pharmacovigilance, and cites contributions from the GDG and various funding partners.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
2026 WHO Malaria Guideline
Same clinical topic · Infectious Diseases
Updated Malaria Treatment Guidelines
Same clinical topic · Infectious Diseases
Guidelines for the management of asymptomatic sexually transmitted infections
Same clinical topic · Infectious Diseases
National Antiretroviral Treatment Guidelines
Same clinical topic · Infectious Diseases
Uganda Malaria Control Program Guidelines 2022
Same clinical topic · Infectious Diseases
Uganda National TB and Leprosy Control Programme Manual
Same clinical topic · Infectious Diseases
Management of severe malaria: a practical handbook
Same clinical topic · Infectious Diseases
Uganda Hepatitis B and C Guidelines
Same clinical topic · Infectious Diseases
Ebola Virus Disease Case Definitions
Same clinical topic · Infectious Diseases